Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting

Background: Almost one-third of fibrosing ILD (fILDs) have a clinical disease behavior similar to IPF, demonstrating a progressive phenotype (PF-ILD). However, there are no globally accepted criteria on the definition of a progressive phenotype in non-IPF fILD yet. Four different definitions have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Torrisi, Sebastiano Emanuele, Kahn, Nicolas, Wälscher, Julia, Polke, Markus, Lee, Joyce S., Molyneaux, Philip L., Sambataro, Francesca Maria, Heussel, Claus Peter, Vancheri, Carlo, Kreuter, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718675/
https://www.ncbi.nlm.nih.gov/pubmed/34975486
http://dx.doi.org/10.3389/fphar.2021.790204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718675/
https://www.ncbi.nlm.nih.gov/pubmed/34975486
http://dx.doi.org/10.3389/fphar.2021.790204

Ejemplares similares